Christopher Seekamp is an accomplished inventor based in Brookfield, WI (US). He has made significant contributions to the field of medical solutions, particularly in the development of hypoallergenic treatments. With a total of 4 patents to his name, Seekamp's work is paving the way for advancements in patient care.

Latest Patents

Seekamp's latest patents focus on ultrapure hypoallergenic solutions of sacrosidase. One of his inventions provides a method for treating individuals who lack endogenous sucrase activity. This method involves orally administering a solution of sacrosidase in a 1:1 glycerol/water mixture, which has an enzymatic activity of at least 7500 IU/mL and a residual papain concentration of less than 10 ng/ml. Another aspect of his work emphasizes the creation of an ultrapure, hypoallergenic sacrosidase solution that does not trigger allergic reactions in patients when administered at a dose of 2.0 mL/day.

Career Highlights

Seekamp is currently associated with Qol Medical LLC, where he continues to innovate and develop new medical solutions. His expertise in hypoallergenic treatments has positioned him as a key player in the medical field.

Collaborations

Seekamp collaborates with various professionals, including his coworker Dayton T Reardan, to enhance the effectiveness of his inventions and broaden their impact.

Conclusion

Christopher Seekamp's contributions to the field of medical solutions through his innovative patents are noteworthy. His work in developing ultrapure hypoallergenic solutions is set to improve the quality of life for many patients.

Profile summary based on public USPTO records.